Generic Pricing Pressure Could Become "Significant" During 2006
This article was originally published in The Pink Sheet Daily
Executive SummaryWith additional ANDAs for already-generic products moving towards approval, the segment will see notable uptick in competition, ABN AMRO's Erdei says.
You may also be interested in...
Association for Accessible Medicines’ interim leader is General Counsel Jeffrey Francer; Chip Davis’ four-and-half year tenure included a total rebrand of the association, a significant legislative victory with the CREATES act – and an abrupt departure for the Healthcare Distribution Alliance.
PDUFA and GDUFA negotiations are expected to begin first, as they usually take the longest to complete, and will be followed by BsUFA talks.